Zepbound® (Tirzepatide) Weight Loss Shots

Used alongside a reduced-calorie diet and increased physical activity, Zepbound helps patients achieve and maintain significant weight loss by targeting two hormones involved in appetite regulation and blood sugar control.

How Zepbound Works

Zepbound is the first FDA-approved medication that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual-action mechanism helps:

• Reduce appetite and food cravings
• Increase feelings of fullness after meals
• Slow stomach emptying
• Improve metabolic health
• Support long-term weight loss when combined with healthy lifestyle changes

Key Benefits

• FDA-approved for chronic weight management
• Once-weekly, easy-to-use subcutaneous injection
• Clinically proven to support substantial weight loss when combined with diet and exercise
• Helps reduce hunger and calorie intake
• Supports long-term weight maintenance
• Also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

Who May Be Eligible?

Zepbound may be prescribed for adults who:

• Have a Body Mass Index (BMI) of 30 kg/m² or higher (obesity), or
• Have a BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as:
  • High blood pressure
  • Type 2 diabetes
  • High cholesterol

Treatment should only be initiated and monitored by a licensed healthcare provider.

Common Side Effects

The most commonly reported side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Stomach pain
• Indigestion
• Decreased appetite
• Injection site reactions

These effects are generally mild to moderate and often improve as treatment continues.

Important Safety Information

Zepbound is not suitable for everyone. It should not be used by individuals with:

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• A known allergy to tirzepatide or any of its ingredients

Seek immediate medical attention if you experience severe abdominal pain, symptoms of pancreatitis, serious allergic reactions, or vision changes. Zepbound should not be used together with other tirzepatide-containing medications or GLP-1 receptor agonists unless specifically directed by a healthcare professional.

Storage

Store unused Zepbound injection pens in a refrigerator at 36°F–46°F (2°C–8°C). Do not freeze. Follow the manufacturer’s storage instructions for handling and use.

Disclaimer

Zepbound is a prescription-only medication. Individual results vary, and the medication should be used only under the supervision of a licensed healthcare provider as part of a comprehensive weight management program that includes healthy eating, physical activity, and regular medical follow-up.

Zepbound weight loss shots, Zepbound injection, tirzepatide weight loss medication, prescription weight loss injection, GLP-1 weight loss medication, GIP and GLP-1 receptor agonist, FDA-approved weight loss medication, chronic weight management, obesity treatment, weekly weight loss injection, medically supervised weight loss, appetite suppressant injection, tirzepatide for weight loss, prescription obesity treatment, Zepbound weight management.